SCHEMBL3217043

SCHEMBL3217043

O=C1COc2cc(S(=O)(=O)Cl)cnc2N1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.35
PIK3R1 P27986 1/20 0.35
MTOR P42345 1/20 0.35
MAPT P10636 4/20 0.35
ALDH1A1 P00352 2/20 0.35
MMP12 P39900 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
PKM P14618 5/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
THRB P10828 1/20 0.33
PARP1 P09874 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3082129 0.78 ALDH1A1 (0.38) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL859012 0.75 MMP12 (0.38) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL15979057 0.75 NR3C2 (0.39) MMP12CYP11B1CYP11B2
SCHEMBL7958200 0.75 MMP12 (0.38) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL10283759 0.75 MMP12 (0.49) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL19707127 0.74 ABL1 (0.53) MAPTPKMTDP1
SCHEMBL29934138 0.74 ABL1 (0.53) MAPTPKMTDP1
SCHEMBL3175004 0.73 LMNA (0.50) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL17095009 0.73 PARP1 (0.37) MAPTALDH1A1MMP12CYP11B1CYP11B2
SCHEMBL13748940 0.72 MMP12 (0.39) MAPTALDH1A1MMP12CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184990-A2 3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY Memory Pharmaceuticals Corporation (US) 2010-05-19 EP disclosed
WO-2010024980-A1 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 WO disclosed
US-20100056491-A1 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US disclosed
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US disclosed
US-20090069337-A1 3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2009-03-12 US disclosed
WO-2009023844-A2 3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069337-A1 3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3A, HTR3B PIK3CD 2986/4885PIK3R1 1374/4885MTOR 2335/4885
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3B, HTR1B PIK3CD 3446/4885PIK3R1 2629/4885MTOR 3720/4885
US-20100056491-A1 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR4, HTR3B PIK3CD 1715/4885PIK3R1 1535/4885MTOR 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.